RNA binding specificity of Ebola virus transcription factor VP30

RNA Biology

Volumn 13, Issue 9, 2016, Pages 783-798

  Schlereth, Julia ^a   Grünweller, Arnold ^a   Biedenkopf, Nadine ^a   Becker, Stephan ^a   Hartmann, Roland K ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Ebola virus (EBOV); electrophoretic gel mobility shift assay; RNA binding specificity; transcription factor; VP30

Indexed keywords

COMPLEMENTARY RNA; GENOMIC RNA; NUCLEIC ACID; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR VP30; UNCLASSIFIED DRUG; VIRAL PROTEIN; MESSENGER RNA; RNA BINDING PROTEIN; VIRUS RNA; VP30 PROTEIN, EBOLA VIRUS;

ARTICLE; BINDING AFFINITY; DNA BASE COMPOSITION; EBOLAVIRUS; GEL MOBILITY SHIFT ASSAY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; RNA BINDING; RNA HYBRIDIZATION; CHEMISTRY; CONFORMATION; EBOLA HEMORRHAGIC FEVER; ENZYME SPECIFICITY; GENE DELETION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PROMOTER REGION; VIROLOGY; VIRUS GENOME; VIRUS REPLICATION;

BASE COMPOSITION; BASE SEQUENCE; EBOLAVIRUS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENOME, VIRAL; HEMORRHAGIC FEVER, EBOLA; NUCLEIC ACID CONFORMATION; PROMOTER REGIONS, GENETIC; RNA, ANTISENSE; RNA, MESSENGER; RNA, VIRAL; RNA-BINDING PROTEINS; SEQUENCE DELETION; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84978083383     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2016.1194160     Document Type: Article

References (33)

1. M.P.Kiley, E.T.Bowen, G.A.Eddy, M.Isaacson, K.M.Johnson, J.B.McCormick, F.A.Murphy, S.R.Pattyn, D.Peters, O.W.Prozesky, et al. Filoviridae:a taxonomic home for Marburg and Ebola viruses? Intervirol 1982; 18:24-32; PMID:7118520; http://dx.doi.org/10.1159/000149300
2. M.J.Adams, E.J.Lefkowitz, A.M.King, E.B.Carstens. Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses. Arch Virol 2014; 159:2831-41; PMID:24906522; http://dx.doi.org/10.1007/s00705-014-2114-3
3. S.Mahanty, M.Bray. Pathogenesis of filoviral haemorraghic fevers. Lancet Infect Dis 2004; 4:487-98; PMID:15288821; http://dx.doi.org/10.1016/S1473-3099(04)01103-X
4. A.Sanchez, M.P.Kiley, B.P.Holloway, D.D.Auperin. Sequence analysis of the Ebola virus genome:organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res 1993; 29:215-40; PMID:8237108; http://dx.doi.org/10.1016/0168-1702(93)90063-S
5. M.Weik, S.Enterlein, K.Schlenz, E.Mühlberger. The Ebola virus genomic replication promoter is bipartite and follows the rule of six. J Virol 2005; 79:10660-71; PMID:16051858; http://dx.doi.org/10.1128/JVI.79.16.10660-10671.2005
6. V.E.Volchkov, V.A.Volchkova, A.A.Chepurnov, V.M.Blinov, O.Dolnik, S.V.Netesov, H.Feldmann. Characterization of the L gene and 5´ trailer region of Ebola virus. J Gen Virol 1999; 80:355-62; PMID:10073695; http://dx.doi.org/10.1099/0022-1317-80-2-355
7. E.Mühlberger, M.Weik, V.E.Volchkov, H.D.Klenk, S.Becker. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J Virol 1999; 73:2333-42; PMID:9971816
8. J.Modrof, E.Mühlberger, H.D.Klenk, S.Becker. Phosphorylation of VP30 impairs Ebola virus transcription. J Biol Chem 2002; 277:33099-104; PMID:12052831; http://dx.doi.org/10.1074/jbc.M203775200
9. M.Weik, J.Modrof, H.D.Klenk, S.Becker, E.Mühlberger. Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol 2002; 76:8532-9; PMID:12163572; http://dx.doi.org/10.1128/JVI.76.17.8532-8539.2002
10. M.J.Martínez, N.Biedenkopf, V.Volchkova, B.Hartlieb, N.Alazard-Dany, O.Reynard, S.Becker, V.Volchkov. Role of Ebola virus VP30 in transcription reinitiation. J Virol 2008; 82:12569-73; PMID:18829754; http://dx.doi.org/10.1128/JVI.01395-08
11. E.Mühlberger, S.Trommer, C.Funke, V.Volchkov, H.D.Klenk, S.Becker. Termini of all mRNA species of Marburg virus:sequence and secondary structure. Virology 1996; 223:376-80; PMID:8806574; http://dx.doi.org/10.1006/viro.1996.0490
12. S.P.John, T.Wang, S.Steffen, S.Longhi, C.S.Schmaljohn, C.B.Jonsson. Ebola virus VP30 is an RNA binding protein. J Virol 2007; 81:8967-76; PMID:17567691; http://dx.doi.org/10.1128/JVI.02523-06
13. T.Ogino, A.K.Banerjee. Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus. Mol Cell 2007; 25:85-97; PMID:17218273; http://dx.doi.org/10.1016/j.molcel.2006.11.013
14. B.Steuten, P.G.Hoch, K.Damm, S.Schneider, K.Köhler, R.Wagner, R.K.Hartmann. Regulation of transcription by 6S RNAs:Insights from the Escherichia coli and Bacillus subtilis model systems. RNA Biol 2014; 11:508-21; PMID:24786589; http://dx.doi.org/10.4161/rna.28827
15. K.Köhler, E.Durchardt-Ferner, M.Lechner, K.Damm, P.G.Hoch, M.Salas, R.K.Hartmann. Structural and mechanistic characterization of 6S RNA from the hyperthermophilic bacterium Aquifex aeolicus. Biochimie 2015; 117:72-86; PMID:25771336; http://dx.doi.org/10.1016/j.biochi.2015.03.004
16. C.C.Heuck, U.Schiele, D.Horn, D.Fronda, E.Ritz. The role of surface charge on the accelerating action of heparin on the antithrombin III-inhibited activity of α-thrombin. J Biol Chem 1985; 260:4598-603; PMID:3988727
17. B.Hartlieb, T.Muziol, W.Weissenhorn, S.Becker. Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. Proc Natl Acad Sci USA 2007; 104:624-9; PMID:17202263; http://dx.doi.org/10.1073/pnas.0606730104
18. B.Liang, Z.Li, S.Jenni, A.A.Rahmeh, B.M.Morin, T.Grant, N.Grigorieff, S.C.Harrison, S.P.Whelan. Structure of the L Protein of Vesicular Stomatitis Virus from Electron Cryomicroscopy. Cell 2015; 162:314-27; PMID:26144317; http://dx.doi.org/10.1016/j.cell.2015.06.018
19. R.Cox, R.K.Plemper. The paramyxovirus polymerase complex as a target for next-generation anti-paramyxovirus therapeutics. Front Microbiol. 2015; 6:459; PMID:26029193; http://dx.doi.org/10.3389/fmicb.2015.00459
20. J.Reguera, P.Gerlach, S.Cusack. Towards a structural understanding of RNA synthesis by negative strand RNA viral polymerases. Curr Opin Struct Biol. 2016; 36:75-84; PMID:26826467; http://dx.doi.org/10.1016/j.sbi.2016.01.002
21. C.V.Filomatori, N.G.Iglesias, S.M.Villordo, D.E.Alvarez, A.V.Gamarnik. RNA sequences and structures required for the recruitment and activity of the dengue virus polymerase. J Biol Chem 2011; 286:6929-39; PMID:21183683; http://dx.doi.org/10.1074/jbc.M110.162289
22. B.Yen, L.C.F.Mulder, O.Martinez, C.F.Basler. Molecular basis for ebolavirus VP35 suppression of human dendritic cell maturation. J Virol 2014; 88:12500-10; PMID:25142601; http://dx.doi.org/10.1128/JVI.02163-14
23. S.J.Tanner, A.Ariza, C.A.Richard, H.F.Kyle, R.L.Dods, M.L.Blondot, W.Wu, J.Trincao, C.H.Trinh, J.A.Hiscox, et al. Crystal structure of the essential transcription antiterminator M2-1 protein of human respiratory syncytial virus and implications of its phosphorylation. Proc Natl Acad Sci USA 2014; 111:1580-5; PMID:24434552; http://dx.doi.org/10.1073/pnas.1317262111
24. M.L.Blondot, V.Dubosclard, J.Fix, S.Lassoued, M.Aumont-Nicaise, F.Bontems, J.F.Eléouet, C.Sizun. Structure and functional analysis of the RNA- and viral phosphoprotein-binding domain of respiratory syncytial virus M2-1 protein. Plos Pathog 2012; 8(5):e1002734; PMID:22675274; http://dx.doi.org/10.1371/journal.ppat.1002734
25. C.Leyrat, M.Renner, K.Harlos, J.T.Huiskonen, J.M.Grimes. Drastic changes in conformational dynamics of the antiterminator M2-1 regulate transcription efficiency in Pneumovirinae. Elife 2014; 3:e02674; PMID:24842877; http://dx.doi.org/10.7554/eLife.02674
26. S.A.Esperante, M.G.Noval, T.A.Altieri, G.A.de Oliveira, J.L.Silva, G.de Prat-Gay. Fine modulation of the respiratory syncytial virus M2-1 protein quaternary structure by reversible zinc removal from its Cys(3)-His(1) motif. Biochem 2013; 52:6779-89; PMID:23984912; http://dx.doi.org/10.1021/bi401029q
27. M.Gößringer, D.Helmecke, K.Köhler, A.Schön, L.A.Kirsebom, A.Bindereif, R.K.Hartmann. Enzymatic RNA Synthesis using Bacteriophage T7 RNA Polymerase In:Handbook of RNA Biochemistry, second edition (eds. R.K.Hartmann, A.Bindereif, A.Schön, E.Westhof), WILEY-VCH, Weinheim, Germany, 2014:pp. 3-27
28. M.Mörl, R.K.Hartmann. Production of RNAs with Homogeneous 5′- and 3′-Ends. In:Handbook of RNA Biochemistry, second edition (eds. R.K.Hartmann, A.Bindereif, A.Schön, E.Westhof), WILEY-VCH, Weinheim, Germany, 2014:pp. 29-44
29. D.Li, D.K.Willkomm, R.K.Hartmann. Minor changes largely restore catalytic activity of archaeal RNase P RNA from Methanothermobacter thermoautotrophicus. Nucleic Acids Res 2009 Jan; 37(1):231-42; PMID:19036794; http://dx.doi.org/10.1093/nar/gkn915
30. N.Biedenkopf, B.Hartlieb, T.Hoenen, S.Becker. Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex:impact on viral transcription and replication. J Biol Chem 2013; 288:11165-74; PMID:23493393; http://dx.doi.org/10.1074/jbc.M113.461285
31. J.Modrof, S.Becker, E.Mühlberger. Ebola virus transcription activator VP30 is a zinc-binding protein. J Virol 2003; 77:3334-8; PMID:12584359; http://dx.doi.org/10.1128/JVI.77.5.3334-3338.2003
32. B.Hartlieb, J.Modrof, E.Mühlberger, H.D.Klenk, S.Becker. Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide. J Biol Chem 2003; 278:41830-6; PMID:12912982; http://dx.doi.org/10.1074/jbc.M307036200
33. Biedenkopf N, Schlereth J, Grünweller A, Becker S, Hartmann RK. RNA-binding of Ebola virus VP30 is essential for activating viral transcription. J Virol. 2016 Jun 8. pii:JVI.00271-16; PMID:27279615